Caprock Group, Inc. Care Dx, Inc. Transaction History

Caprock Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 07, 2021	SELL	$59.15 - $91.99 $176,267 - $274,130	-2,980 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$63.02 - $95.11 $187,799 - $283,427	2,980 New	2,980 $273,000
Q1 2021 Apr 29, 2021	SELL	$57.62 - $95.6 $259,578 - $430,678	-4,505 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$41.43 - $77.09 $186,642 - $347,290	4,505 New	4,505 $326,000
Q3 2020 Oct 29, 2020	SELL	$30.88 - $37.94 $207,050 - $254,387	-6,705 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$18.95 - $35.43 $127,059 - $237,558	6,705 New	6,705 $238,000
Q3 2019 Oct 31, 2019	SELL	$20.03 - $40.08 $164,346 - $328,856	-8,205 Closed	0 $0
Q3 2018 Oct 17, 2018	BUY	$12.1 - $28.85 $99,280 - $236,714	8,205 New	8,205 $237,000

218

51M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.19B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.